| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From Roche Diagnostics GmbH,
*
Penzberg, Germany; and the Institute for Virology, Infectiology and Epidemiology
and Medical Diagnostic Laboratory, Stuttgart, Germany
The COBAS AmpliPrep instrument (Roche Diagnostics GmbH, D-68305 Mannheim, Germany) automates the entire sample preparation process of nucleic acid isolation from serum or plasma for polymerase chain reaction analysis. We report the analytical performance of the LightCycler Parvovirus B19 Quantification Kit (Roche Diagnostics) using nucleic acids isolated with the COBAS AmpliPrep instrument. Nucleic acids were extracted using the Total Nucleic Acid Isolation Kit (Roche Diagnostics) and amplified with the LightCycler Parvovirus B19 Quantification Kit. The kit combination processes 72 samples per 8-hour shift. The lower detection limit is 234 IU/ml at a 95% hit-rate, linear range approximately 104-1010 IU/ml, and overall precision 16 to 40%. Relative sensitivity and specificity in routine samples from pregnant women are 100% and 93%, respectively. Identification of a persistent parvovirus B19-infected individual by the polymerase chain reaction among 51 anti-parvovirus B19 IgM-negative samples underlines the importance of additional nucleic acid testing in pregnancy and its superiority to serology in identifying the risk of parvovirus B19 transmission via blood or blood products. Combination of the Total Nucleic Acid Isolation Kit on the COBAS AmpliPrep instrument with the LightCycler Parvovirus B19 Quantification Kit provides a reliable and time-saving tool for sensitive and accurate detection of parvovirus B19 DNA.
This article has been cited by other articles:
 |
|
 |
|
  A. Gotsch, A. Schubert, A. Bombis, M. Wiedmann, M. Zauke, and S. Schorling Nuclease-Resistant Single-Stranded DNA Controls for Nucleic Acid Amplification Assays J. Clin. Microbiol., August 1, 2007; 45(8): 2570 - 2574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Perrin, J. M. Pawlotsky, M. Bouvier-Alias, C. Sarrazin, S. Zeuzem, and G. Colucci Multicenter Performance Evaluation of a New TaqMan PCR Assay for Monitoring Human Immunodeficiency Virus RNA Load J. Clin. Microbiol., December 1, 2006; 44(12): 4371 - 4375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ronsin, A. Pillet, C. Bali, and G.-A. Denoyel Evaluation of the COBAS AmpliPrep-Total Nucleic Acid Isolation-COBAS TaqMan Hepatitis B Virus (HBV) Quantitative Test and Comparison to the VERSANT HBV DNA 3.0 Assay J. Clin. Microbiol., April 1, 2006; 44(4): 1390 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Espy, J. R. Uhl, L. M. Sloan, S. P. Buckwalter, M. F. Jones, E. A. Vetter, J. D. C. Yao, N. L. Wengenack, J. E. Rosenblatt, F. R. Cockerill III, et al. Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing Clin. Microbiol. Rev., January 1, 2006; 19(1): 165 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Hourfar, U. Michelsen, M. Schmidt, A. Berger, E. Seifried, and W. K. Roth High-Throughput Purification of Viral RNA Based on Novel Aqueous Chemistry for Nucleic Acid Isolation Clin. Chem., July 1, 2005; 51(7): 1217 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Candotti, N. Etiz, A. Parsyan, and J.-P. Allain Identification and Characterization of Persistent Human Erythrovirus Infection in Blood Donor Samples J. Virol., November 15, 2004; 78(22): 12169 - 12178. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
